UNSPSC 51412901: Micinicate

This classification denotes a vasodilating agent with the molecular formula C23H27NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M87S131A7F, chemically known as nicotinic acid, ester with cis-3,3,5-trimethylcyclohexyl ( -)-mandelate but generally known as micinicate, which bears US NIH Compound Identifier 172291. European Medicines Agency schedules Micinicate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08943MIG.

UNSPSC 51412901 Micinicate, a Commodity code, covers advanced life support and emergency medications that state and local governments procure for fire departments, emergency medical services, and health agencies — specifically epinephrine, labetalol, adenosine, diltiazem, and other parenteral drugs administered in acute care settings. State and local buyers include city fire departments, county EMS systems, state health agencies, and multistate cooperative purchasing alliances serving hospital networks and government health plans. The scope spans sealed-bid procurements for specific medication line items with firm pricing and delivery guarantees, as well as strategic market-intelligence solicitations from state health commissions exploring direct-to-manufacturer pharmacy programs to bypass traditional pharmacy benefit managers and wholesalers.

Activity under this code spans Florida, Texas, and Minnesota, with municipal fire services and state health authorities driving recent demand. The City of Tampa Fire Rescue's Purchasing Department posted IFB 26P00188 on April 24, 2026 (due April 8, 2026) for four Advanced Life Support Medications line items — labetalol, epinephrine, adenosine, and diltiazem — with a one-year contract term, $40,000 estimated value, and a 5 percent SLBE bid discount. Minnesota's Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products, establishing standing contracts through authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) effective July 1, 2026, with two-year terms and optional extensions through June 30, 2028. Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription fulfillment models, signaling state-level interest in reshaping pharmaceutical supply chains outside traditional PBM and GPO relationships. All procurement vehicles require FDA compliance, safety data sheets, cGMP certification, and DSCSA compliance.